Drug: Zyprexa
2006 sales: $4.4 billion
Manufacturer: Eli Lilly
Safety concern: Warning; weight gain, metabolic problems
Related Articles:
> Lilly strengthens Zyprexa warnings. Report
> Study: 86% of docs cut Zyprexa use. Report
> Lilly to pay $500M to settle Zyprexa claims. Report
> Lilly ignored Zyprexa safety data on weight, blood sugar. Report
> Lilly accused of promoting off-label Zyprexa use. Report
> NYT accuses Lilly of hiding safety problems. Report